UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of hereditary inclusion body myopathy myoblasts: possible primary impairment of apoptotic events

Cell death and differentiation, 2007-11, Vol.14 (11), p.1916-1924

2007

Volltextzugriff (PDF)

Tyrphostins that suppress the growth of human papilloma virus 16-immortalized human keratinocytes

The Journal of pharmacology and experimental therapeutics, 1999-09, Vol.290 (3), p.1442

1999

Volltextzugriff (PDF)

Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors

British journal of dermatology (1951), 1999-11, Vol.141 (5), p.802-810

1999

Volltextzugriff (PDF)

Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin

The Journal of clinical investigation, 1993-06, Vol.91 (6), p.2488-2496

1993

Volltextzugriff (PDF)

The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth

Human reproduction (Oxford), 2004-09, Vol.19 (9), p.1957-1967

2004

Volltextzugriff (PDF)

Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes

Cancer research (Chicago, Ill.), 1997-09, Vol.57 (17), p.3741-3750

1997

Volltextzugriff (PDF)

Tyrosine kinase inhibitors suppress the growth of non-hodgkin B lymphomas

The Journal of pharmacology and experimental therapeutics, 2002-10, Vol.303 (1), p.163-171

2002

Volltextzugriff (PDF)

G.O.5 Impairment of signal transduction pathways in hereditary inclusion body myopathy

Neuromuscular disorders : NMD, 2006-10, Vol.16 (9), p.647-647

2006

Volltextzugriff (PDF)

Inhibitors that target protein kinases for the treatment of ovarian carcinoma

American journal of obstetrics and gynecology, 2003-05, Vol.188 (5), p.1283-1290

2003

Volltextzugriff (PDF)

Src protein and tyrosine-phosphorylated protein profiles in marrow stroma during osteogenic stimulation

Journal of cellular biochemistry, 1998-06, Vol.69 (3), p.316-325

1998

Volltextzugriff (PDF)

Current Topics in Cellular Regulation

1, 1992

Volltextzugriff (PDF)

Current Topics in Cellular Regulation

1, 1990

Volltextzugriff (PDF)

Frameshift and splice-junction mutations in the sterol 24-hydroxylase gene cause cerebrotendinous xanthomatosis in jews of Moroccan origin

The Journal of clinical investigation, 1993, Vol.91 (6), p.2488-2496

1993

Volltextzugriff (PDF)

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

Oncogene, 2001-05, Vol.20 (20), p.2499-2513

2001

Volltextzugriff (PDF)

Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling

Oncogene, 2016-05, Vol.35 (20), p.2675-2680

2016

Volltextzugriff (PDF)

Information-theoretic analysis of phenotype changes in early stages of carcinogenesis

Proceedings of the National Academy of Sciences - PNAS, 2010-06, Vol.107 (22), p.10324-10329

2010

Volltextzugriff (PDF)

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

Immunity (Cambridge, Mass.), 1999, Vol.10 (1), p.105-115

1999

Volltextzugriff (PDF)

On a fundamental structure of gene networks in living cells

Proceedings of the National Academy of Sciences - PNAS, 2012-03, Vol.109 (12), p.4702-4707

2012

Volltextzugriff (PDF)

Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity

The Journal of biological chemistry, 2000-08, Vol.275 (32), p.24935-24944

2000

Volltextzugriff (PDF)

Active Src Elevates the Expression of β-Catenin by Enhancement of Cap-Dependent Translation

Molecular and Cellular Biology, 2005-06, Vol.25 (12), p.5031-5039

2005

Volltextzugriff (PDF)

Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase

Biochemical pharmacology, 2006-05, Vol.71 (10), p.1422-1434

2006

Volltextzugriff (PDF)

High-Affinity Epidermal Growth Factor Receptor (EGFR) Irreversible Inhibitors with Diminished Chemical Reactivities as Positron Emission Tomography (PET)-Imaging Agent Candidates of EGFR Overexpressing Tumors

Journal of medicinal chemistry, 2005-08, Vol.48 (16), p.5337-5348

2005

Volltextzugriff (PDF)

Convergence of logic of cellular regulation in different premalignant cells by an information theoretic approach

BMC systems biology, 2011-03, Vol.5 (1), p.42-42, Article 42

2011

Volltextzugriff (PDF)

Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors

Nuclear medicine and biology, 2007, Vol.34 (1), p.55-70

2007

Volltextzugriff (PDF)

The effect of tyrosine‐specific protein phosphorylation on the assembly of adherens‐type junctions

The EMBO journal, 1992-05, Vol.11 (5), p.1733-1742

1992

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(76)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(47)
Animals
(35)
Biological And Medical Sciences
(33)
Humans
(27)
Phosphorylation
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)
Mice
(18)
Cell Biology
(17)
Biochemistry & Molecular Biology
(16)
Protein-Tyrosine Kinases - Antagonists & Inhibitors
(16)
Medical Sciences
(15)
Enzyme Inhibitors - Pharmacology
(13)
Tyrphostins
(13)
Pharmacology. Drug Treatments
(12)
Cell Division - Drug Effects
(11)
Rats
(11)
Signal Transduction
(11)
Nitriles - Pharmacology
(10)
Tyrphostins - Pharmacology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of hereditary inclusion body myopathy myoblasts: possible primary impairment of apoptotic events

Tyrphostins that suppress the growth of human papilloma virus 16-immortalized human keratinocytes

Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors

Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin

The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth

Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes

Tyrosine kinase inhibitors suppress the growth of non-hodgkin B lymphomas

G.O.5 Impairment of signal transduction pathways in hereditary inclusion body myopathy

Inhibitors that target protein kinases for the treatment of ovarian carcinoma

Src protein and tyrosine-phosphorylated protein profiles in marrow stroma during osteogenic stimulation

Current Topics in Cellular Regulation

Current Topics in Cellular Regulation

Frameshift and splice-junction mutations in the sterol 24-hydroxylase gene cause cerebrotendinous xanthomatosis in jews of Moroccan origin

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling

Information-theoretic analysis of phenotype changes in early stages of carcinogenesis

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

On a fundamental structure of gene networks in living cells

Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity

Active Src Elevates the Expression of β-Catenin by Enhancement of Cap-Dependent Translation

Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase

High-Affinity Epidermal Growth Factor Receptor (EGFR) Irreversible Inhibitors with Diminished Chemical Reactivities as Positron Emission Tomography (PET)-Imaging Agent Candidates of EGFR Overexpressing Tumors

Convergence of logic of cellular regulation in different premalignant cells by an information theoretic approach

Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors

The effect of tyrosine‐specific protein phosphorylation on the assembly of adherens‐type junctions

Suchergebnisse filtern